EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,313,256 | +879.5% | 197,403 | +867.0% | 0.01% | +600.0% |
| Q2 2023 | $440,352 | -5.6% | 20,415 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $466,710 | -90.3% | 21,637 | -92.8% | 0.00% | -87.5% |
| Q4 2022 | $4,814,694 | -20.6% | 300,168 | -21.6% | 0.01% | -20.0% |
| Q3 2022 | $6,061,000 | -88.3% | 382,741 | -84.7% | 0.01% | -88.0% |
| Q2 2022 | $52,015,000 | +330.6% | 2,498,377 | +368.9% | 0.08% | +418.8% |
| Q1 2022 | $12,079,000 | +84.1% | 532,843 | +53.8% | 0.02% | +100.0% |
| Q4 2021 | $6,560,000 | -54.7% | 346,520 | -50.4% | 0.01% | -60.0% |
| Q3 2021 | $14,491,000 | +1087.8% | 699,247 | +944.0% | 0.02% | +900.0% |
| Q2 2021 | $1,220,000 | +20.8% | 66,977 | +49.8% | 0.00% | 0.0% |
| Q1 2021 | $1,010,000 | -73.3% | 44,714 | -76.3% | 0.00% | -66.7% |
| Q4 2020 | $3,789,000 | -68.4% | 188,794 | -61.5% | 0.01% | -72.7% |
| Q3 2020 | $11,998,000 | -52.7% | 490,721 | -54.1% | 0.02% | -54.2% |
| Q2 2020 | $25,353,000 | +202.5% | 1,067,979 | +119.4% | 0.05% | +166.7% |
| Q1 2020 | $8,382,000 | -74.4% | 486,733 | -73.8% | 0.02% | -62.5% |
| Q4 2019 | $32,781,000 | -12.5% | 1,860,407 | -12.2% | 0.05% | -18.6% |
| Q3 2019 | $37,484,000 | +2.6% | 2,120,046 | +24.0% | 0.06% | +3.5% |
| Q2 2019 | $36,546,000 | +78.0% | 1,710,137 | +98.3% | 0.06% | +67.6% |
| Q1 2019 | $20,526,000 | -34.7% | 862,429 | -46.0% | 0.03% | -38.2% |
| Q4 2018 | $31,435,000 | +512.6% | 1,598,167 | +451.9% | 0.06% | +587.5% |
| Q3 2018 | $5,131,000 | -40.6% | 289,550 | -27.9% | 0.01% | -38.5% |
| Q2 2018 | $8,641,000 | -9.6% | 401,530 | -7.0% | 0.01% | -13.3% |
| Q1 2018 | $9,560,000 | -33.7% | 431,630 | -9.0% | 0.02% | -25.0% |
| Q4 2017 | $14,420,000 | +48.0% | 474,330 | +17.9% | 0.02% | +42.9% |
| Q3 2017 | $9,746,000 | -36.9% | 402,230 | -35.9% | 0.01% | -39.1% |
| Q2 2017 | $15,456,000 | +311.5% | 627,530 | +262.0% | 0.02% | +283.3% |
| Q1 2017 | $3,756,000 | +10.8% | 173,333 | -23.8% | 0.01% | +20.0% |
| Q4 2016 | $3,390,000 | -23.0% | 227,370 | -34.0% | 0.01% | -28.6% |
| Q3 2016 | $4,403,000 | +2777.8% | 344,253 | +1652.5% | 0.01% | – |
| Q2 2016 | $153,000 | +115.5% | 19,643 | +11.3% | 0.00% | – |
| Q1 2016 | $71,000 | -31.7% | 17,643 | -4.3% | 0.00% | – |
| Q4 2015 | $104,000 | +1.0% | 18,443 | 0.0% | 0.00% | – |
| Q3 2015 | $103,000 | +63.5% | 18,443 | +9.5% | 0.00% | – |
| Q2 2015 | $63,000 | +43.2% | 16,843 | -1.2% | 0.00% | – |
| Q1 2015 | $44,000 | +76.0% | 17,043 | 0.0% | 0.00% | – |
| Q4 2014 | $25,000 | 0.0% | 17,043 | +3.0% | 0.00% | – |
| Q3 2014 | $25,000 | -77.9% | 16,543 | -50.4% | 0.00% | – |
| Q2 2014 | $113,000 | +59.2% | 33,356 | +65.2% | 0.00% | – |
| Q1 2014 | $71,000 | -41.3% | 20,188 | +2.5% | 0.00% | – |
| Q4 2013 | $121,000 | -20.4% | 19,688 | -24.8% | 0.00% | – |
| Q3 2013 | $152,000 | +29.9% | 26,188 | +1.9% | 0.00% | – |
| Q2 2013 | $117,000 | – | 25,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |